Dr. Michael Vincent Stock, MD

Dr. Stock practices at Advanced Surgery Center - Saint Louis in Saint Louis, Missouri.

Dr. Stock's NPI, 1730442500, was assigned on June 18, 2012. Dr. Stock graduated from Washington University School of Medicine in 2012. Dr. Stock holds Missouri license 2016004847.

Dr. Stock's primary practice is Advanced Surgery Center - Saint Louis, at 12607 Olive Boulevard, Saint Louis, MO 63141. The practice phone is (314) 205-1610.

Dr. Stock's primary practice is Advanced Surgery Center - Saint Louis in Saint Louis, Missouri. Dr. Stock is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Stock to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stock practices, 6 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Stock's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Stock is licensed in Missouri.

CMS data shows 4,200 Medicare services from Dr. Stock across 8 procedure codes in 2024, for 1,060 Medicare patients. Medicare paid $638,291 for them.

CMS counts 1,060 Medicare patients who saw Dr. Stock in 2024. The largest group is 65 to 74, with 606 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stock's median patient age at 73, with 59% women.

In 2024, Dr. Stock wrote 383 Medicare Part D claims for 204 patients. 61% of them were for generic drugs. CMS names the drug for 296 of them, across 8 drugs with 11 or more claims each, at $4,890 in total drug cost. In 2023, CMS named 151 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Stock for performance year 2024, reported as part of a group. Dr. Stock accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,576 procedures of cataract surgery by Dr. Stock, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Stock, published from 2011 to 2021. The most frequent topics are Vision Disorders and Visual Acuity. Dr. Stock's most frequent co-authors are Elizabeth F. Baze, MD, Mary Gilbert Lawrence, MD and David E. Vollman, MD.

CMS Open Payments shows 188 general payments to Dr. Stock from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Alcon Laboratories Inc paid the most, $2,730.

Dr. Stock graduated from Washington University School of Medicine in 2012.